Stevanato group announces public offering of ordinary shares

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn) (“stevanato group,” or the “company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares. stevanato group is offering $150,000,000 of its ordinary shares (the “company offering”), and stevanato holding s.
STVN Ratings Summary
STVN Quant Ranking